Skip to main content

Advertisement

SpringerLink
Log in

ASO Author Reflections: The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Odisio BC, Simoneau E, Holmes AA, Conrad CH, Vauthey JN. Fast-track two-stage hepatectomy using a hybrid interventional radiology/operating suite as alternative option to associated liver partition and portal vein ligation for staged hepatectomy procedure. J Am Coll Surg. 2018;227(2):e5–10.

    PubMed  Google Scholar 

  2. Kawaguchi Y, Hasegawa K, Tzeng CD, et al. Performance of a modified three-level classification in stratifying open liver resection procedures in terms of complexity and postoperative morbidity. Br J Surg. 2020;107(3):258–267.

  3. Kawaguchi Y, Kopetz S, Newhook TE, et al. Mutation status of RAS, TP53, and SMAD4 is superior to mutation status of ras alone for predicting prognosis after resection of colorectal liver metastases. Clin Cancer Res. 2019;25(19):5843–51.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Kawaguchi Y, Vaythey JN. The Landmark Series: randomized control trials examining perioperative chemotherapy and postoperative adjuvant chemotherapy for resectable colorectal liver metastasis. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08777-z.

  5. Bridgewater JA, Pugh SA, Maishman T, et al. Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol. 2020;21(3):398–411.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Kawaguchi Y, Kopetz S, Lillemoe HA, et al. A new surveillance algorithm after resection of colorectal liver metastases based on changes in recurrence risk and RAS mutation status. J Natl Comprehensive Cancer Netw JNCCN. (in press).

Download references

Funding

This research was supported in part by the National Institutes of Health (T32 CA 009599) and the MD Anderson Cancer Center Support Grant, CA016672.

Author information

Authors and Affiliations

  1. Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

    Yoshikuni Kawaguchi MD & Jean-Nicolas Vauthey MD

  2. Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan

    Yoshikuni Kawaguchi MD

Authors
  1. Yoshikuni Kawaguchi MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jean-Nicolas Vauthey MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yoshikuni Kawaguchi MD.

Ethics declarations

Disclosures

Yoshikuni Kawaguchi and Jean-Nicolas Vauthey have no conflicts of interest to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kawaguchi, Y., Vauthey, JN. ASO Author Reflections: The Landmark Series: Randomized Control Trials Examining Perioperative Chemotherapy and Postoperative Adjuvant Chemotherapy for Resectable Colorectal Liver Metastasis. Ann Surg Oncol 27, 4271–4272 (2020). https://doi.org/10.1245/s10434-020-08809-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08809-8

Search

Navigation